Skip to main content
Caplight Logo









Celogics

Celogics

Private
Mukilteo, WashingtonHealthcare & Life Scienceshttps://celogics.com

Last Round

Corporate Funding

Oct 26, 2021

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Celogics operates in Healthcare & Life Sciences and is based in Mukilteo, Washington. Its latest recorded funding round was a Corporate Funding round in October 2021.

Celogics is a biotechnology company that develops, manufactures, and commercializes human induced pluripotent stem cell (iPSC)-derived cell products for drug discovery, safety testing, and biological research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Celogics Comparables

Compare Celogics with similar companies based on industry and business-model similarity.

Celogics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axol Bioscience
82%
bit.bio
81%
iXCells Biotechnologies
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Celogics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingOct 26, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jin Chang

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 62% MoM.

  • Apr 6, 2026

    Monthly visitors grew 58% MoM, from 1.2K to 2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Celogics Filings

Explore SEC and related filing metadata, where available.

Celogics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Celogics's valuation, stock price, and market status.

Is Celogics a public or private company?

Celogics is a private company.

What is the current stock price of Celogics?

Celogics is a private company, so its shares have no public market price. Caplight tracks Celogics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Celogics worth (valuation)?

Valuation information for Celogics is not publicly available.

Can I buy Celogics stock?

Celogics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Celogics's last funding round?

Celogics's most recent funding round was Corporate Funding on October 26, 2021.

Who are the main investors in Celogics?

Investor information for Celogics is not publicly disclosed.

Will Celogics IPO soon?

No public IPO plans have been announced for Celogics.

How can I track Celogics secondary market activity?

Caplight tracks bids, offers, and trades in Celogics's shares on secondary markets.

Firmographic Details

HeadquartersMukilteo, Washington
Employee Range5
Year Founded2021
Last FundingOct 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?